omega-n-methylarginine has been researched along with 2,3-dinor-6-ketoprostaglandin f1alpha in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (2,3-dinor-6-ketoprostaglandin f1alpha) | Trials (2,3-dinor-6-ketoprostaglandin f1alpha) | Recent Studies (post-2010) (2,3-dinor-6-ketoprostaglandin f1alpha) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 201 | 39 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, NJ; Gainer, JV; Murphey, LJ; Vaughan, DE | 1 |
1 trial(s) available for omega-n-methylarginine and 2,3-dinor-6-ketoprostaglandin f1alpha
| Article | Year |
|---|---|
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Adrenergic beta-Antagonists; Adult; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Forearm; Humans; Indomethacin; Infusions, Intra-Arterial; Male; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Receptor, Bradykinin B2; Regional Blood Flow; Tissue Plasminogen Activator; Vasodilation; Vasodilator Agents | 2000 |